The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 401–500 of 1,004
Telomeres and telomerase as targets for anticancer drug development
Olaussen, K. A., Dubrana, K., Dômont, J., Spano, J., Sabatier, L., & Soria, J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.007 · Cited by 108
Guide RNAs with 5′ Caps and Novel Box C/D snoRNA-like Domains for Modification of snRNAs in Metazoa
Tycowski, K. T., Aab, A., & STEITZ, J. A. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.003 · Cited by 102
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Xiong, J., Fan, S., Meng, Q., Schramm, L., Wang, C., Bouzahza, B., Zhou, J., Zafonte, B. T., Goldberg, I. D., Haddad, B. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8668-8690.2003 · Cited by 110
“The core of the mammalian telomerase holoenzyme is the catalytic subunit, telomerase reverse transcriptase (TERT; also known as hEST2), which is a reverse transcriptase that adds hexameric DNA repeats (TTAGGG) that correspond to the telomerase RNA component known as TERC (also known as hTR) (12, 20, 44).”
BackgroundTelomerase: regulation, function and transformation
Dong, C. K., Masutomi, K., & Hahn, W. C. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.12.005 · Cited by 100
Seimiya, H., Tanji, M., Oh‐hara, T., Tomida, A., Naasani, I., & Tsuruo, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0910 · Cited by 105
Fission yeast Ccq1 is telomerase recruiter and local checkpoint controller
Tomita, K., & Cooper, J. P. (2008) · Genes & Development · doi:10.1101/gad.498608 · Cited by 112
“In human cells, hTERT (the Est2 homolog) and the RNA template hTR are known telomerase components (Feng et al. 1995; Meyerson et al. 1997).”
BackgroundBrümmendorf, T. H., & Balabanov, S. (2006) · Leukemia · doi:10.1038/sj.leu.2404339 · Cited by 102
Evidence for UV-associated activation of telomerase in human skin.
Ueda, M., Ouhtit, A., Bito, T., Nakazawa, K., Lübbe, J., Ichihashi, M., Yamasaki, H., & Nakazawa, H. (1997) · PubMed · Cited by 95
Telomere Maintenance as a Target for Drug Discovery
Sekaran, V. G., Soares, J., & Jarstfer, M. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400528t · Cited by 97
A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
Romei, C., & Elisei, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041726 · Cited by 103
“In addition, TERT has been shown to play a major role in the activation of telomerase during malignant transformation of cells [55,56].”
BackgroundGuiducci, C., Cerone, M. A., & Bacchetti, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204145 · Cited by 109
“As reported (Feng et al., 1995; Mitchell et al., 1999) the activity speci®ed by hTR MuC generates a single PCR product rather than the typical ladder Figure 2 Cell recovery after selection.”
MethodTelomerase and its potential for therapeutic intervention
Phatak, P., & Burger, A. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707374 · Cited by 90
“The telomere/telomerase complex In vitro, hTERC and hTERT are sufficient to bestow telomerase activity (Feng et al., 1995; Nakamura et al., 1997).”
BackgroundInfluentialThe significance of telomerase activation and cellular immortalization in human cancer
Newbold, R. F. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.539 · Cited by 100
“The human genes encoding these components have been cloned (Feng et al., 1995; Meyerson et al., 1997) and the availability of these genes enabled it to be shown that the primary mode of regulation (i.e. repression) of telomerase in human cells is through silencing of the hTERT gene via…”
BackgroundYajima, T., Yagihashi, A., Kameshima, H., Kobayashi, D., Furuya, D., Hirata, K., & Watanabe, N. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2441 · Cited by 99
Telomeres, Telomerase and Ageing
Saretzki, G. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-13-2835-0_9 · Cited by 93
Bednarek, A. K., Şahin, A. A., Brenner, A., Johnston, D. A., & Aldaz, C. M. (1997) · PubMed · Cited by 93
Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?
Greaves, M. F. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)30016-4 · Cited by 95
Zeng, X., & Rao, M. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.017 · Cited by 92
MacKenzie, K. L., Franco, S., May, C., Sadelain, M., & Moore, M. A. S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4982 · Cited by 92
Gavathiotis, E., Heald, R. A., Stevens, M. F. G., & Searle, M. S. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20011217)40:24<4749::aid-anie4749>3.0.co;2-i · Cited by 102
Telomeres: Implications for Cancer Development
Bernal, A., & Tusell, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010294 · Cited by 100
“After Mt-hTERC expression there were no changes on telomere length [184] and reduced TRF2 levels resulted in an increased number of γH2AX or 53BP1 foci at chromosome ends [185].”
BackgroundInfluentialMolecular interactions between telomerase and the tumor suppressor protein p53 in vitro
Li, H., Cao, Y., Berndt, M. C., Funder, J. W., & Liu, J. (1999) · Oncogene · doi:10.1038/sj.onc.1203061 · Cited by 102
“…RNA subunit contains the template for telomeric DNA addition and is essential for telomerase activity (Blasco et al., 1996; Broccoli et al., 1996; Feng et al., 1995; Greider and Blackburn, 1989; Kondo et al., 1998; Lee et al., 1998; Niida et al., 1998; Shippen-Lentz and Blackburn, 1990; Tsao et…”
BackgroundYokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., Wan, X., Niwa, K., & Tamaya, T. (1998) · PubMed · Cited by 107
A miniature yeast telomerase RNA functions in vivo and reconstitutes activity in vitro
Zappulla, D. C., Goodrich, K. J., & Cech, T. R. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1019 · Cited by 106
Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
Pang, L. Y., & Argyle, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.010 · Cited by 105
“The protein component acts as a reverse transcriptase and catalyses the addition of telomeric repeats onto the ends of chromosomes using the RNA subunit as a template [36-38].”
MethodChromosome healing: Spontaneous and programmed de novo telomere formation by telomerase
Melek, M., & Shippen, D. E. (1996) · BioEssays · doi:10.1002/bies.950180408 · Cited by 95
Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts
de Magalhães, J. P., Chainiaux, F., Remacle, J., & Toussaint, O. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02973-3 · Cited by 90
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
MacKenzie, D., Watters, A. K., To, J. T., Young, M. W., Muratori, J., Wilkoff, M. H., Abraham, R. G., Plummer, M. M., & Zhang, D. (2021) · Cancers · doi:10.3390/cancers13102384 · Cited by 100
“Telomerase adds the TTAGGG one at a time to telomeres when they are getting too short [7,8].”
BackgroundDown-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol
Eitsuka, T., Nakagawa, K., & Miyazawa, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.029 · Cited by 94
Compton, S. A., Choi, J.-H., Cesare, A. J., Özgür, S., & Griffith, J. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3672 · Cited by 85
“It can extend the proliferative life span of cells by catalyzing the addition of telomeric DNA onto the ends of telomeres using an internal RNA template complimentary to the telomere sequence (12, 13).”
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo, Y., Gan, Y., Song, S., Johnston, J. S., Xiao, X., Wientjes, M. G., & Au, J. L. ‐. (2003) · PubMed · Cited by 90
Knekt, J�rvinen, R., Dich, J., & Hakulinen, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<852::aid-ijc9>3.0.co;2-s · Cited by 321
Yashima, K., Piatyszek, M. A., Saboorian, H. M., Virmani, A. K., Brown, D. F., Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.110 · Cited by 96
Abdul‐Ghani, R., Ohana, P., Matouk, I., Ayesh, S. K., Ayesh, B. M., Laster, M., Bibi, O., Giladi, H., Molnar-Kimber, K. L., Sughayer, M. A., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0196 · Cited by 98
Folini, M., Brambilla, C., Villa, R., Gandellini, P., Vignati, S., Paduano, F., Daidone, M. G., & Zaffaroni, N. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.002 · Cited by 98
“The telomerase core enzyme consists of an RNA component (hTERC) that provides the template for the de novo synthesis of telomeric DNA [3], and a catalytic subunit (hTERT) with reverse transcriptase activity [4,5].”
BackgroundXiang, H., Wang, J., Mao, Y., Liu, M., Reddy, V. N., & Li, D. W. (2002) · Oncogene · doi:10.1038/sj.onc.1205455 · Cited by 98
“The catalytic core of human telomerase is composed of an RNA subunit known as hTER (human telomerase RNA) and a protein subunit named as hTERT (human telomerase reverse transcriptase) (Feng et al., 1995; Greider, 1996; Nakamura et al., 1997; Collins, 2000).”
BackgroundHerbert, B.-S., Wright, W. E., & Shay, J. W. (2001) · Breast Cancer Research · doi:10.1186/bcr288 · Cited by 88
Hammond, P. W., Lively, T. N., & Cech, T. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.296 · Cited by 88
“The RNA component of telomerase has also been identified in several fungi and mammals (5, 8, 29, 37), with protein subunits yet to be purified.”
BackgroundBrennan, S. K., Wang, Q., Tressler, R., Harley, C. B., Go, N. F., Bassett, E., Huff, C. A., Jones, R. J., & Matsui, W. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012487 · Cited by 92
“Several approaches have been developed to target telomerase including antisense RNA directed against TERT, small molecules that stabilize G-quadruplexes, and oligonucleotides acting as direct inhibitors of the reverse transcriptase activity [27–31].”
BackgroundSelf-citationTERC promotes cellular inflammatory response independent of telomerase
Liu, H., Yang, Y., Ge, Y., Liu, J., & Zhao, Y. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz584 · Cited by 88
“TERC serves as a template for reverse transcriptase TERT, which adds GGTTAG repeats to chromosome ends (1).”
BackgroundTelomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas, M. A., Reis, R. J. S., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., Goyal, R. K., Hurley, L. H., Anderson, K. C., & Munshi, N. C. (2003) · PubMed · Cited by 102
Hirose, M., Abe-Hashimoto, J., Ogura, K., Tahara, H., Ide, T., & Yoshimura, T. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01438310 · Cited by 88
“Telomerase, a ribonucleoprotein enzyme, utilizes its own RNA as a template to add the telomeric DNA to the ends of chromosomes, thereby preventing the telomeric sequence loss at each cell division (de Lange 1994; Feng et al. 1995; Collins et al. 1995).”
BackgroundTelomere length in myelodysplastic syndromes
Boultwood, J., Fidler, C., Kušec, R., Rack, K. A., Elliott, P., Atoyebi, O. A., Chapman, R., Oscier, D. G., & Wainscoat, J. S. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199712)56:4<288::aid-ajh16>3.0.co;2-5 · Cited by 88
Kumaki, F., Kawai, T., Hiroi, S., Shinomiya, N., Ozeki, Y., Ferrans, V. J., & Torikata, C. (2001) · Human Pathology · doi:10.1053/hupa.2001.21567 · Cited by 94
Connective tissue diseases, multimorbidity and the ageing lung
Spagnolo, P., Cordier, J.-F., & Cottin, V. (2016) · European Respiratory Journal · doi:10.1183/13993003.00829-2015 · Cited by 95
Characters, functions and clinical perspectives of long non-coding RNAs
Wu, R., Su, Y., Wu, H., Dai, Y., Zhao, M., & Lu, Q. (2016) · Molecular Genetics and Genomics · doi:10.1007/s00438-016-1179-y · Cited by 91
Ciliate Telomerase Biochemistry
Collins, K. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.187 · Cited by 88
Yashima, K., Milchgrub, S., Gollahon, L., Maitra, A., Saboorian, M. H., Shay, J. W., & Gazdar, A. F. (1998) · PubMed · Cited by 87
Uehara, H. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00442-6 · Cited by 88
Boundary elements of the Tetrahymena telomerase RNA template and alignment domains.Preprint
Autexier, C., & Greider, C. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2227 · Cited by 104
“The yeast and mammalian telomerase RNAs lack the conserved sequence present in ciliate telomerase RNAs (Singer and Gottschling 1994; Blasco et al. 1995; Feng et al. 1995; McEachem and Blackburn 1995).”
BackgroundSelf-citationImmortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR
Wang, W., Zhang, T., Wu, C., Wang, S., Wang, Y., Li, H., & Wang, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177348 · Cited by 101
Self-citationTargeting telomerase-expressing cancer cells
Ouellette, M. M., Wright, W. E., & Shay, J. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01279.x · Cited by 88
Life under the Microscope: Single-Molecule Fluorescence Highlights the RNA World
Ray, S., Widom, J. R., & Walter, N. G. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00519 · Cited by 94
The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis
Lewandowski, J. P., Lee, J. C., Hwang, T., Sunwoo, H., Goldstein, J. M., Groff, A. F., Chang, N. P., Mallard, W., Williams, A., Henao-Meija, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12970-4 · Cited by 90
Telomerase and the Aging Cell: Implications for Human Health
Fossel, M. (1998) · JAMA · doi:10.1001/jama.279.21.1732 · Cited by 85
Burger, A., Bibby, M., & Double, J. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.90 · Cited by 86
“Although earlier studies had demonstrated that the human telomerase RNA component is expressed in many adult organs including liver, the authors were not able to detect telomerase activity (Avilion et al, 1995; Feng et al, 1995).”
BackgroundPrevalence of Telomerase Activity in Human Cancer
Chen, C., & Chen, R. (2011) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(11)60043-0 · Cited by 102
Palos, K. R., Yu, L., Railey, C. E., Dittrich, A. C. N., & Nelson, A. D. L. (2023) · The Plant Cell · doi:10.1093/plcell/koad027 · Cited by 86
“Despite its characterization in ciliates, yeast, and vertebrates in the 20th century (Greider and Blackburn 1989; Singer and Gottschling 1994; Feng et al. 1995), TR was only recently characterized in plants (Fajkus et al. 2019; Song et al. 2019; Dew-Budd et al. 2020).”
BackgroundhTERT mRNA expression correlates with telomerase activity in human breast cancer
Kirkpatrick, K. L., Clark, G. M., Ghilchick, M., Newbold, R. F., & Mokbel, K. (2003) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1374 · Cited by 95
“However, the levels of hTR (and TEP1) expression have been shown to be unrelated to the level of telomerase activity.(8,9,12,13) whereas induction of hTERT expression has been shown to be essential for telomerase activation in cell-lines.”
BackgroundStructural Insight into the interaction of Flavonoids with Human Telomeric Sequence
Tawani, A., & Kumar, A. (2015) · Scientific Reports · doi:10.1038/srep17574 · Cited by 92
Ducrest, A., Amacker, M., Mathieu, Y., Cuthbert, A. P., Trott, D. A., Newbold, R. F., Nabholz, M., & Lingner, J. (2001) · PubMed · Cited by 101
Sugita, M., Tanaka, N., Davidson, S. A., Sekiya, S., Varella-Garcia, M., West, J. D., Drabkin, H. A., & Gemmill, R. M. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00135-1 · Cited by 93
Hukezalie, K. R., Thumati, N. R., Côté, H. C. F., & Wong, J. M. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047505 · Cited by 84
“The catalytic core of the telomerase enzyme is a ribonucleoprotein composed of telomerase reverse transcriptase (TERT), the catalytic subunit [5], and telomerase RNA (TER) [6].”
BackgroundTelomerase Regulation from Beginning to the End
MacNeil, D., Bensoussan, H., & Autexier, C. (2016) · Genes · doi:10.3390/genes7090064 · Cited by 96
“The dyskerin homologue in S. cerevisiae (Cbf5p) is required at snoRNA genes during transcription to prevent RNAPII read-through and promote efficient transcription termination [41].”
BackgroundInfluentialImmortalization and Transformation of Human Cells
C. Hahn, W. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15045-x · Cited by 84
Hartmann, U., Brümmendorf, T. H., Balabanov, S., Thiede, C., Illme, T., & Schaich, M. A. (2005) · PubMed · Cited by 90
Long-term molecular and cellular stability of human neural stem cell lines
Villa, A., Navarro‐Galve, B., Bueno, C., Franco, S., Blasco, M. A., & Martínez-Serrano, A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.025 · Cited by 91
Inhibition of Telomerase Activity of Melanoma Cellsin Vitroby Antisense Oligonucleotides
Glukhov, A. I., Зимник, О. В., Гордеев, С. А., & Severin, E. S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8801 · Cited by 92
Wu, A., Ichihashi, M., & Ueda, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10<2038::aid-cncr22>3.0.co;2-a · Cited by 83
“Telomerase is a ribonucleoprotein enzyme (an RNA-dependent DNA polymerase) that catalyzes the addition of telomeric repeats (TTAGGG)n to telomeres, the distal ends of eukaryotic chromosomes.(1,2) Telomeres cap chromosome ends and protect them from degradation and end-to-end fusion.”
BackgroundDynamics of the membrana granulosa during expansion of the ovarian follicular antrum
Rodgers, R. J., Irving-Rodgers, H., van Wezel, I. L., Krupa, M., & Lavranos, T. C. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00430-5 · Cited by 83
BRÜMMENDORF, T. H., RUFER, N., HOLYOAKE, T. L., MACIEJEWSKI, J., BARNETT, M. J., EAVES, C. J., EAVES, A. C., YOUNG, N., & LANSDORP, P. M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03598.x · Cited by 83
Binz, N., Shalaby, T., Rivera, P., Shin‐ya, K., & Grotzer, M. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.025 · Cited by 94
“ends by using the RNA segment within its molecule as a template [9–11].”
MethodYang, H., Kyo, S., Takatura, M., & Sun, L. (2001) · PubMed · Cited by 96
Telomerase is Not an Epidermal Stem Cell Marker and is Downregulated by Calcium
Bickenbach, J. R., Vormwald‐Dogan, V., Bachor, C., Bleuel, K., Schnapp, G., & Boukamp, P. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00420.x · Cited by 87
Polymerization Defects within Human Telomerase Are Distinct from Telomerase RNA and TEP1 Binding
Beattie, T. L., Zhou, W., Robinson, M. O., & Harrington, L. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3329 · Cited by 83
“The full-length human telomerase RNA, spanning nucleotides 1 to 451 (Feng et al., 1995) was cloned as described in Bryan et al.”
MethodTherapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 96
Chang, C., Kuo, I., Lin, J., Lu, Y., Chen, C., Back, H., Lou, P., & Chang, T. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490100 · Cited by 85
Living forever and dying in the attempt
Hayflick, L. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.003 · Cited by 90
Ford, L. P., Suh, J. M., Wright, W. E., & Shay, J. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9084-9091.2000 · Cited by 96
“The human telomerase holoenzyme contains a catalytic protein component, hTERT, and a 451-base integral RNA, human telomerase RNA (hTR) (19, 23), that are essential for assembling telomerase activity in vitro and in vivo (59).”
BackgroundFajkus, J., Fulnečková, J., Hulánová, M., Berková, K., Říha, K., & Matyášek, R. (1998) · Molecular and General Genetics MGG · doi:10.1007/s004380050918 · Cited by 86
“The composition of the telomerase complex was ®rst studied in Tetrahymena (Greider and Blackburn 1985) and more recently in Euplotes (Lingner and Cech 1996; Lingner et al. 1997) and other organisms including man (Feng et al. 1995; Harrington et al. 1997a; Harrington et al. 1997b).”
Wang, L., Soria, J., Kemp, B. L., Liu, D. D., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 95
Xu, D., Gruber, A., Björkholm, M., Peterson, C., & Pisa, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690480 · Cited by 82
“Only lately is our understanding of the regulation of telomerase activity starting to emerge thanks to the identification of the human telomerase subunits (Feng et al, 1995; Harrington et al, 1997; Kilian et al, 1997; Meyerson et al, 1997; Nakamura et al, 1997).”
BackgroundLansdorp, P. M. (1998) · Molecular Biology of B-Cell and T-Cell Development · doi:10.1007/978-1-4757-2778-4_2 · Cited by 83
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma
Nouso, K., Urabe, Y., Higashi, T., Nakatsukasa, H., Hino, N., Ashida, K., Kinugasa, N., Yoshida, K., Uematsu, S., & Tsuji, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<232::aid-cncr7>3.0.co;2-n · Cited by 84
Management of multicellular senescence and oxidative stress
Haines, D. D., Juhasz, B., & Tosaki, A. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12074 · Cited by 79
“Indeed, telomerase activity is significantly diminished in cells nearing their Hayflick limit both in vivo and in vitro [3, 13].”
BackgroundInfluentialThompson, P. A., Drissi, R., Muscal, J. A., Panditharatna, E., Fouladi, M., Ingle, A. M., Ahern, C. H., Reid, J. M., Lin, T., Weigel, B. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1117 · Cited by 84
“9 Sex Male 13 (65) Female 7 (35) Race White 14 (70) Asian 1 (5) American Indian or Alaska Native 0 (0) Black or African American 1 (5) Unknown 4 (20) Ethnicity Non-Hispanic 15 (75) Hispanic 4 (20) Unknown 1 (5) Diagnoses Ewing sarcoma 6 (30) Neuroblastoma 6 (30) Hepatocellular carcinoma, fibrolamellar 2 (10) Other 6 (…”
BackgroundDez, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.598 · Cited by 75
“the rest of the RNA component [designated hTR (2)] of human”
BackgroundTanaka, M., Kyo, S., Takakura, M., Kanaya, T., Sagawa, T., Yamashita, K., Okada, Y., Hiyama, E., & Inoue, M. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65712-4 · Cited by 92
Boltze, C., Mundschenk, J., Unger, N., Schneider‐Stock, R., Peters, B., Mawrin, C., Hoang‐Vu, C., Roessner, A., & Lehnert, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021299 · Cited by 84
BRCA1 Localization to the Telomere and Its Loss from the Telomere in Response to DNA Damage
Ballal, R. D., Saha, T., Fan, S., Haddad, B. R., & Rosen, E. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025825 · Cited by 90
Kurz, D. J., Hong, Y., Trivier, E., Huang, H.-L., Decary, S., Zang, G. H., Lüscher, T. F., & Erusalimsky, J. D. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000069624.55424.61 · Cited by 80
2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai, S., Kondo, Y., Koga, S., Komata, T., Barna, B. P., & Kondo, S. (2000) · PubMed · Cited by 88
Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology
Schmitt, A. M., & Chang, H. Y. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026492 · Cited by 81
“The telomere RNA component (TERC) is a critical subunit of the ribonucleoprotein telomerase complex and encodes the template for the hexanucleotide repeats that compose the telomere sequence (Feng et al. 1995).”
BackgroundTelomere‐based DNA damage responses: a new approach to melanoma
Puri, N., Eller, M. S., Byers, H. R., Dykstra, S. G., Kubera, J., & Gilchrest, B. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1774com · Cited by 80
Cifuentes-Rojas, C., & Shippen, D. E. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.003 · Cited by 64
Differential regulation of telomerase activity by six telomerase subunits
Chang, J. T., Chen, Y., Yang, H., Chen, C., & Cheng, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03025.x · Cited by 88
Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase
Piera‐Velazquez, S., Jimenez, S. A., & Stokes, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10116 · Cited by 79
Dome, J. S., Bockhold, C. A., Li, S. M., Baker, S., Green, D. M., Perlman, E. J., Hill, D. A., & Breslow, N. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.562 · Cited by 82
Leem, S., Londoño‐Vallejo, A., Kim, J.-H., Bui, H., Tubacher, E., Solomon, G. G., Park, J., Horikawa, I., Kouprina, N., Barrett, J. C., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205122 · Cited by 85
“The RNA component of telomerase is expressed in most embryonic and adult tissues (Feng et al., 1995; Avilion et al., 1996); in contrast, expression of TERT is highly regulated and correlates with telomerase activity (Kilian et al., 1997; Meyerson et al., 1997; Nakamura et al., 1997).”
BackgroundHorikawa, I., Oshimura, M., & Barrett, J. C. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199806)22:2<65::aid-mc1>3.0.co;2-j · Cited by 79
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.